Rosa Miceli

13 papers receiving 591 citations

Rosa Miceli's Hit Papers

Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial 2023 · 83 citations
830+1+3Years since publication50100150200

Peers

Rosa Miceli
Comparison fields: 5 of 60
  • Psychiatry and Mental health 405
  • Applied Microbiology and Biotechnology 18
  • Pathology and Forensic Medicine 143
  • Neurology 29
  • Infectious Diseases 63
Replace Robert Nett with:
Robert Nett United States
Ludmyla Rekeda United States
Annick De Jaeger Belgium
Monica Siniscalchi Italy
Khalil El‐Chammas United States
Kamal Masaki United States
Kęstutis Petrikonis Lithuania
Hans Søe Riis Jespersen Denmark
Amy Y. L. Li Hong Kong
N. D. W. Lionel Sri Lanka
Rosa Miceli relative to Robert Nett United States Robert Nett's profile →
Citations per field
00.5×9.8×
Robert Nett · 1×
Citations per year

Countries citing papers authored by Rosa Miceli

Since Specialization
Citations

This map shows the geographic impact of Rosa Miceli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Miceli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Miceli more than expected).

Fields of papers citing papers by Rosa Miceli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Miceli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Miceli. The network helps show where Rosa Miceli may publish in the future.

Co-authors

The 25 scholars most cited alongside Rosa Miceli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rosa Miceli Line = papers co-authored together Rosa Miceli links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1
Atogepant for the Preventive Treatment of Migraine
Hit paper breakdown →
2021203
2 2018157
3
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial
Hit paper breakdown →
202383
4 202145
5 202337
6 201935
7 202317
8 202213
9 20215
10 20254
11 20212
12 20192
13 20221
14 20220
15 20210

About Rosa Miceli

Rosa Miceli is a scholar working on Psychiatry and Mental health, Surgery, Pathology and Forensic Medicine, Sensory Systems and Immunology, having authored 15 papers that have together received 604 indexed citations. Recurring topics across this work include Migraine and Headache Studies (12 papers), Olfactory and Sensory Function Studies (2 papers), Biomedical and Chemical Research (2 papers), Cardiovascular Syncope and Autonomic Disorders (1 paper), Trigeminal Neuralgia and Treatments (1 paper), Psoriasis: Treatment and Pathogenesis (1 paper), Fungal Plant Pathogen Control (1 paper) and Toxin Mechanisms and Immunotoxins (1 paper). The work is most often cited by research in Psychiatry and Mental health (405 citations), Applied Microbiology and Biotechnology (18 citations), Pathology and Forensic Medicine (143 citations), Neurology (29 citations) and Infectious Diseases (63 citations). Rosa Miceli has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Michelle Finnegan, Joel M. Trugman, Lawrence Severt, Hua Guo, Richard B. Lipton, Peter J. Goadsby, Jessica Ailani, David Melnick, Michael W. Dunne and Alena Jandourek. Their work appears in journals such as Neurology, Cephalalgia, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, The Lancet and Journal of Crohn s and Colitis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact